IN-VITRO ACTIVITY OF THE NEW GLYCOPEPTIDE LY333328 AGAINST MULTIPLY RESISTANT GRAM-POSITIVE CLINICAL ISOLATES

Authors
GARCIAGARROTE F CERCENADO E ALCALA L BOUZA E
Citation
F. Garciagarrote et al., IN-VITRO ACTIVITY OF THE NEW GLYCOPEPTIDE LY333328 AGAINST MULTIPLY RESISTANT GRAM-POSITIVE CLINICAL ISOLATES, Antimicrobial agents and chemotherapy, 42(9), 1998, pp. 2452-2455
Citations number
12
Categorie Soggetti
Pharmacology & Pharmacy",Microbiology
Journal title
Antimicrobial agents and chemotherapy → ACNP
ISSN journal
00664804
Volume
42
Issue
9
Year of publication
1998
Pages
2452 - 2455
Database
ISI
SICI code
0066-4804(1998)42:9<2452:IAOTNG>2.0.ZU;2-S
Abstract
The in vitro activity of LY333328 was compared with those of vancomyci n and teicoplanin against 425 grampositive clinical isolates? includin g a variety of multiply resistant strains. LY333328 at less than or eq ual to 4 mu g/ml inhibited all microorganisms tested, including methic illin- and teicoplanin-resistant staphylococci, glycopeptide-resistant enterococci, penicillin- and multiply resistant pneumococci, and viri dans and beta-hemolytic streptococci.